Pregnancy Safe Skincare Ingredients: What the Science Says About What to Avoid — and Why

Pregnancy changes the terms of engagement with skincare. Ingredients used for years without a second thought — retinol, salicylic acid, certain sunscreen filters — suddenly carry questions that most guides answer with lists rather than reasoning. That is a disservice to pregnant patients who deserve to understand not just what to avoid but why: the biochemical mechanisms, the nature of the evidence, and where the actual risk lies versus where precaution fills the gaps.

Dermatologists and OB-GYNs approach ingredient safety during pregnancy through a framework that weighs systemic absorption, route of exposure, and strength of evidence. Applying that framework to a skincare routine produces very different advice than blanket avoidance — and allows you to retain much of what works while substituting where the risk profile genuinely warrants it.

## Key Takeaways - **Retinoids Carry Genuine Risk:** Oral retinoids (isotretinoin, acitretin) are FDA Category X teratogens. Topical forms are still recommended to avoid — not because data shows clear harm, but because systemic exposure through high-concentration leave-on formulas cannot be fully excluded. - **BHA Concentration and Format Both Matter:** The American College of Obstetricians and Gynecologists endorses low-dose topical salicylic acid (2% or below) in rinse-off formats as safe during pregnancy — a very different risk profile from high-concentration peels. - **Strong Safe Alternatives Exist:** Azelaic acid, vitamin C, niacinamide, hyaluronic acid, low-concentration AHAs, and mineral sunscreens all have favorable pregnancy safety profiles with established clinical use. - **Precautionary Principle in Practice:** "No evidence of harm" is not the same as "evidence of safety." Where systemic absorption is significant and fetal safety data is limited, avoidance remains the appropriate default regardless of reassuring early findings. ## How Dermatologists Actually Assess Ingredient Risk During Pregnancy The historic FDA pregnancy category system (A through X) was retired in 2015 and replaced by the Pregnancy and Lactation Labeling Rule, but the underlying risk framework it organized remains clinically relevant. For topical skincare specifically, the critical variable is the degree to which a topically applied ingredient crosses the skin barrier and reaches systemic circulation — where it becomes capable of affecting fetal development. Hydroquinone, for instance, is absorbed at 35–45% of the applied topical dose — well above the threshold dermatologists consider negligible. That absorption rate, combined with limited controlled safety data in pregnant populations, is why dermatologists recommend avoiding it regardless of whether animal studies demonstrate teratogenicity. The concern is not that existing research confirms harm; it is that the absorption is substantial enough that absence of evidence does not translate to confidence in safety. Hyaluronic acid sits at the opposite end of the risk spectrum. With a molecular weight above 50,000 Daltons in most formulations, it does not penetrate beyond the stratum corneum. No systemic absorption occurs at meaningful levels, and no safety concerns have been documented across decades of clinical and cosmetic use. Between those poles sits the majority of skincare actives — each requiring individual assessment rather than a categorical response. ## The Clear Avoid List: Mechanisms, Not Just Rules **Retinoids** carry the most clearly documented risk profile of any skincare active during pregnancy, though the distinction between oral and topical forms is critical. Oral isotretinoin (and acitretin, etretinate) are unambiguous FDA Category X teratogens. They activate retinoic acid receptors (RAR-α) systemically, disrupting the transcription factors that guide cranial neural crest cell differentiation during early embryogenesis. The resulting defects — craniofacial malformations, cardiac structural abnormalities, central nervous system defects, microtia — are both well-documented and severe. Topical retinoids present a more contested picture. A 2025 Nordic cohort study published in the *British Journal of Dermatology*, covering 33,000 pregnancies across Denmark, Iceland, Norway, and Sweden, found no statistically significant increase in major congenital malformations among infants exposed to topical retinoids (3.3% vs. 3.0% in unexposed infants). Despite this reassurance, current dermatological and obstetric consensus maintains the recommendation to avoid topical retinoids during pregnancy. High-concentration leave-on formulations — retinol serums at 0.5–1%, prescription tretinoin — carry meaningful systemic exposure that cannot be fully characterized, and the precautionary principle applies where fetal development is at stake and safe alternatives exist. **Hydroquinone** is absorbed at 35–45% of the applied topical dose. No controlled human study has demonstrated teratogenic effects, but the absorption rate alone — combined with limited controlled safety data and the ready availability of safer alternatives (azelaic acid, vitamin C, tranexamic acid) for addressing hyperpigmentation — places it in the avoid category during pregnancy. **Chemical sunscreen filters, particularly oxybenzone (benzophenone-3),** have documented estrogenic activity at human-relevant concentrations. Oxybenzone has been detected in breast milk, urine, and placental tissue. A published study identified an association between high urinary oxybenzone levels and neonatal Hirschsprung's disease, a congenital gastrointestinal condition. The mechanism is endocrine disruption rather than direct teratogenicity, and causation is not established. Mineral alternatives — zinc oxide and titanium dioxide — carry no systemic absorption concerns and represent the straightforward safe substitute. **High-concentration salicylic acid** requires precise framing. The risk historically attributed to salicylic acid during pregnancy derives from oral salicylate toxicity — aspirin at high doses causes fetal renal and cardiovascular complications via prostaglandin pathway suppression. Topical salicylic acid at low concentrations in rinse-off formats does not replicate that exposure pathway. ACOG specifically distinguishes between these use cases and endorses topical application at 2% or below in rinse-off formulations as safe. ## The Likely Safe List: Where the Evidence Points **Azelaic acid** holds FDA Pregnancy Category B status (from the legacy system), meaning animal studies showed no fetal risk and no adequate human studies demonstrated harm. Clinically, it is a dermatologist-prescribed treatment for pregnancy-related melasma and acne, and its use during pregnancy is supported by both dermatology and obstetric guidelines at concentrations of 10–20%. **Niacinamide (vitamin B3)** is an essential nutrient with an extensive cosmetic and clinical safety record. Topical concentrations used in skincare (typically 2–10%) deliver meaningful barrier support, sebum regulation, and anti-inflammatory benefit without documented fetal safety concerns. **Vitamin C** — whether as L-ascorbic acid, ascorbyl glucoside, or sodium ascorbyl phosphate — carries no documented teratogenicity signal and functions as an essential nutrient required for fetal collagen synthesis and immune development. Low-molecular-weight vitamin C derivatives absorb transdermally, but no safety concerns have been identified at cosmetic concentrations. **Glycolic and lactic acid** at concentrations of 10% or below exert primarily surface-level exfoliation with negligible systemic absorption. High-concentration AHA peels (30%+) involve more significant barrier disruption and should be avoided during pregnancy. **Mineral sunscreens** with zinc oxide and titanium dioxide reflect and scatter UV via physical mechanisms. Neither ingredient is absorbed systemically at significant levels, and both have been used safely in pregnancy for decades. Current dermatological guidance from a 2025 *Frontiers in Medicine* review recommends broad-spectrum mineral-based sunscreens, preferably tinted with iron oxides to address visible light concerns, as optimal for pregnant patients. **Benzoyl peroxide,** while transdermally absorbed to a limited degree, is rapidly metabolized to benzoic acid at the skin surface — a compound present in many foods and widely used as a food preservative. No teratogenic signal has emerged in the available literature, and it is frequently cited as an acceptable option for pregnancy acne management. ## Building a Pregnancy Skincare Routine A functional morning routine during pregnancy follows a clear sequence: a gentle non-foaming or low-pH cleanser, a vitamin C serum (L-ascorbic acid or a stabilized derivative), a niacinamide moisturizer with ceramides for barrier support, and a mineral SPF 30+ broad-spectrum sunscreen with zinc oxide or titanium dioxide. For acne-prone skin, a 2% salicylic acid rinse-off cleanser can replace the standard cleanser. For hyperpigmentation or melasma — which affects up to 70% of pregnant patients — azelaic acid 10–15% applied before moisturizer provides a clinically validated, pregnancy-appropriate treatment. The evening routine requires the most significant modification. Retinol and tretinoin, which anchor many established night routines, need to be replaced. Bakuchiol — a plant-derived compound that activates retinoid receptors through a partially overlapping mechanism — has emerging evidence for cell-turnover and anti-aging benefit. A 2019 study in the *British Journal of Dermatology* found bakuchiol equivalent to retinol 0.5% for wrinkle reduction and pigmentation improvement over 12 weeks, with fewer adverse events. It carries no known teratogenic signal, though it remains outside formal pregnancy-safe dermatological guidelines; discuss with your OB before adding it. ## Frequently Asked Questions ### Is retinol safe during pregnancy? Topical retinol is recommended to avoid during pregnancy by most dermatological and obstetric authorities, despite a 2025 Nordic cohort study finding no significant increase in major malformations with topical retinoid exposure. High-concentration leave-on formulas carry systemic exposure that cannot be fully excluded, and safer alternatives exist for every benefit retinol provides. ### Can I use a salicylic acid face wash while pregnant? Yes, if the concentration is 2% or below and the product is a rinse-off formula. The American College of Obstetricians and Gynecologists endorses this use as safe during pregnancy. High-concentration salicylic acid peels (20–30%) should be avoided. ### What can I use instead of retinol during pregnancy? Azelaic acid (10–20%) addresses both acne and hyperpigmentation with an FDA Pregnancy Category B safety profile and clinical use during pregnancy. Bakuchiol is an emerging plant-based retinol alternative with a favorable safety profile, though formal pregnancy-safe designation from dermatology societies is pending — discuss with your OB. ### Is vitamin C serum safe during pregnancy? Yes. L-ascorbic acid and its stabilized derivatives carry no documented teratogenicity signal and have been widely used in skincare formulations without reported adverse effects in pregnancy. ### When should I start modifying my skincare routine for pregnancy? From confirmed pregnancy, ideally earlier if planning to conceive. Organogenesis — when fetal organs form and are most vulnerable to teratogenic exposure — occurs during weeks 3–8, before many people know they are pregnant. This is why dermatologists recommend transitioning away from retinoids for anyone actively trying to conceive. ## The Framework Behind the Rules Pregnancy skincare advice fails in two ways: blanket prohibitions that eliminate ingredients without mechanistic justification, and dismissive reassurances that ignore the biology of systemic absorption. A more useful approach distinguishes between ingredients with documented teratogenic risk (oral retinoids), high absorption without adequate safety data (hydroquinone), documented endocrine disruption potential (oxybenzone), and genuinely low-risk options at appropriate concentrations and formats (salicylic acid below 2% in rinse-off, vitamin C, niacinamide, mineral SPF). Retain what the evidence supports. Replace what it doesn't. And understand that the ingredient you defer for nine months — retinol included — will be waiting on the other side with its evidence fully intact.